CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 188 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03366454
NCT03366454N/ACompleted
CompareCT.gov

Implementing a Combination of Clinical Parameters (Rapid Diagnostic Tests (RDTs), Biomarkers, and Standard of Care Procedures (SoCs) for the Etiology Diagnoses of Pneumonia in Pediatric Patients to Improve Clinical Management in Indonesia.

INA-RESPOND Secretariat·observational·Posted Dec 8, 2017·Updated Jun 4, 2025

In Brief

An observational study for Pneumonia. Completed, enrolled 188 participants across 4 sites.

Detailed Summary

Participants who meet the inclusion and exclusion criteria will be enrolled and then having a daily follow up for maximum of 13 days' hospitalization. Next follow up will be taken time at day 14th after hospitalization date, either on ward or policlinic. The participations will be ended by day 30th after hospitalization date when the called follow up is done by investigator.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesIndonesia
CollaboratorsUnited States Agency for International Development (USAID), Indonesia Research Partnership on Infectious Disease (INA-RESPOND)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 8, 2017
Enrollment StartJul 4, 2017
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.6 years ago